Non-coding RNA as mediators in microenvironment-breast cancer cell communication

Area of Science:

• Oncology
• Molecular Biology
• Biotechnology

Background:

• The tumor microenvironment significantly influences cancer cell survival, angiogenesis, metastasis, and dormancy.
• Non-coding RNAs (ncRNAs) are emerging as critical mediators in cancer cell-microenvironment crosstalk.
• Targeting ncRNA interactions presents potential therapeutic strategies for cancer treatment.

Purpose of the Study:

• To explore methods for effectively blocking or delivering ncRNAs to manage cancer progression.
• To investigate the potential of mesenchymal stem cells (MSCs) for targeted ncRNA delivery.
• To identify novel drug targets within the tumor microenvironment.

Main Methods:

• Review of existing literature on the role of the tumor microenvironment and ncRNAs in cancer.
• Focus on the application of mesenchymal stem cells (MSCs) for delivering ncRNAs and antagomirs.
• Discussion of MSC-mediated delivery mechanisms and their interaction with cancer cells.

Main Results:

• MSCs are safe, readily available 'off-the-shelf' allogeneic cells.
• MSCs can be engineered to deliver ncRNAs or antagomirs to cancer cells.
• This strategy holds promise for preventing metastasis, inducing dormancy, or reversing dormancy.

Conclusions:

• Mesenchymal stem cells represent a viable platform for targeted nucleic acid delivery in cancer therapy.
• MSC-based delivery of ncRNAs offers a potential new avenue for treating cancer by modulating the tumor microenvironment.
• Further research into the advances and potential challenges of this therapeutic approach is warranted.